MDL 3140 · N.D. Florida · FDA Warning Dec 2025

Stop Paying for Unprovable Depo-Provera Leads

Case Compass verifies Depo-Provera use and meningioma diagnosis, builds a clean exposure timeline, and routes high-score claims to the right team — without replacing your CRM or case management.

CRM and case management agnostic · Works with your existing stack

↑ 2×+ Leads with usable proof

↓ 90% Cost per viable claim

< 8 min Time-to-qualification

100% Audit-trail coverage

How It Works

Medical-record-ready intake, from first contact to case packet

Case Compass structures the messy reality of pharmaceutical intake — collecting injection records, imaging reports, and diagnosis documentation — then scores each claim and routes it to the right team automatically.

Assign & collect the right records

Dynamic intake forms and call center automation scripts target injection history, MRI/CT reports, and diagnosis documentation upfront.

Logic-branch on evidence gaps

Claims with missing records trigger automated follow-up. Claims with complete proof route directly to attorney review.

Build the exposure timeline automatically

Duration on drug, last injection date, diagnosis date, and latency — calculated and structured into a clean case packet.

Case Compass Depo-Provera Intake Workflow

The Problem

Depo-Provera intake breaks in the same three places

High-volume pharmaceutical intake fails when evidence is messy, scattered, and hard to verify fast.

No proof of injections

Claimants remember getting "the shot" but can't locate clinic records, pharmacy history, or insurance claims to confirm Depo-Provera specifically — or the dates.

Vague diagnosis without imaging

"Brain tumor" isn't enough. Without an MRI/CT report or surgical/pathology note confirming meningioma, the claim can't be substantiated for MDL threshold requirements.

Teams waste hours on timelines

Reconstructing exposure duration, diagnosis dates, and treatment history across multiple providers, portals, and years of records is manual, slow, and error-prone.

What Case Compass Does

We turn messy medical narratives
into litigable, exportable case files

Evidence-first intake

Dynamic forms and call center automation scripts collect the right documents up front: injection history, MRI/CT reports, surgical notes, pharmacy records, and insurance claims — before a case worker touches the file.

Timeline + scoring engine

Auto-build exposure duration, injection-to-diagnosis latency, key dates, and severity indicators. Every claim exits intake with a litigability score and a clear evidence gap report.

Call center + smart routing

Route high-score claims to your call center agents or attorney review instantly. Deduplicate inbound leads, suppress repeats, and automate follow-up sequences for claims awaiting records.

What You Can Validate in Minutes

Every dimension of a Depo-Provera claim — captured and scored

This maps directly into your scoring model and form logic.

Use / Exposure

Depo-Provera use confirmed (clinic/pharmacy/claims)

Estimated start and stop dates

Duration on drug (months/years)

Last injection date

Other progestin/hormone exposures

Injury / Diagnosis

Meningioma diagnosis confirmed (MRI/CT or surgical/pathology report)

Date of diagnosis

Diagnosis method (imaging/provider note/surgery)

Treatment path: monitoring / surgery / radiation

Exposure-to-diagnosis latency

Impact & Records

Neurological symptoms (vision, hearing, cognitive)

Lost wages / diminished capacity

Ongoing care and treatment costs

Uploadable records (MRI, op note, EOB, clinic record)

Provider list for record requests

How It Works

From first contact to attorney-ready case packet

Four steps. No rip-and-replace. Works alongside your existing stack.

Capture

Dynamic intake form and call center automation script collect exposure history, diagnosis details, and contact information.

Verify

Request or upload medical records. Normalize provider terminology, confirm Depo-Provera and meningioma specifics.

Score

Exposure duration + diagnosis + severity + record completeness = litigability score with evidence gap report.

Deliver

Push clean case packets (CSV/PDF) to your CRM. Route high-score leads to your call center agents, callbacks, or attorney review.

The Litigation Landscape

What's changed — and what it means for intake

Factual context for your team and your intake strategy.

MDL

Centralized in MDL 3140

Depo-Provera meningioma cases are centralized in MDL 3140 (N.D. Florida), with ongoing case-management orders that include threshold proof requirements for case submission.

FDA

FDA prescribing update — Dec 2025

The FDA updated U.S. prescribing information for Depo-Provera in December 2025 to add a meningioma risk warning for prolonged use of injectable medroxyprogesterone acetate.

SCIENCE

Peer-reviewed evidence

Published analysis has reported increased meningioma risk associated with prolonged injectable DMPA exposure, establishing a scientific basis for causation arguments.

INTAKE

Threshold proof matters now

With MDL case management orders tightening, claims without verifiable injection history and confirmed imaging diagnosis face early dismissal risk. Get records before you sign.

No Rip-and-Replace

Works with the tools you already use

Case Compass sits between marketing and your existing systems — capturing and qualifying claims, then pushing structured data into the platforms you rely on.

CRM agnostic (Salesforce, Litify, SmartAdvocate, Filevine)

Case management agnostic (Clio, MyCase, CASEpeer, TrialWorks)

Exportable case packets (CSV and PDF)

Deduplication + source attribution

Complete audit trail for every claim

Live transfer, callback, and automated follow-up routing

What Firms See

Measurable impact on your intake operation

Outcomes vary by firm — these reflect conservative ranges from firms using evidence-first intake.

↓ Cost

Lower cost per signed case by filtering non-viable claims before they reach case workers

↑ Proof

Higher percentage of leads with usable medical evidence before file review

↓ Time

Reduced time-to-qualification through automated record requests and evidence scoring

↑ Quality

Cleaner case packets entering your CRM — scored, structured, and audit-trailed

Common Questions

What firms ask before getting started

What documents do you collect to confirm Depo-Provera use?

We collect and verify: injection records from clinics or pharmacies, insurance claims and EOBs showing DMPA administration, provider notes referencing Depo-Provera, and pharmacy dispensing records. We normalize terminology across providers and build a complete exposure timeline with start date, stop date, duration, and last injection date.

Can you handle claimants who don't have records yet?

Yes. Case Compass captures provider names, clinic locations, and approximate dates of service to facilitate record requests on the claimant's behalf. We track request status, follow up automatically, and score cases on completeness — so you always know which leads are viable versus pending documentation.

How do you score "likely viable" vs "needs more proof"?

Our scoring engine evaluates: confirmed Depo-Provera use (duration, recency, last injection date), confirmed meningioma diagnosis (MRI/CT, surgical or pathology report), exposure-to-diagnosis latency, treatment intensity (watchful waiting vs surgery vs radiation), and symptom severity. Each dimension is scored and weighted to produce an overall litigability score with a clear evidence gap report.

Do you integrate with Litify, Clio, Salesforce, or other platforms?

Yes. Case Compass is CRM and case management agnostic. We push structured case data into Litify, Salesforce, Filevine, SmartAdvocate, Clio, MyCase, CASEpeer, TrialWorks, and other platforms via API. You receive fully structured, exportable case packets (CSV and PDF) with complete audit trails and source attribution.

Can the call center do live transfers for high-score claims?

Yes. Case Compass provides call center intake automation that your call center team can use to perform warm live transfers to your attorney team for leads that meet your viability threshold in real time. Lower-scoring leads can be routed to automated callback sequences, follow-up flows, or a pending records queue — keeping your attorneys focused on the highest-value claims.

Depo-Provera Meningioma Intake Software — Case Compass

Case Compass is the leading medical-record-ready intake automation platform for Depo-Provera meningioma litigation. Our intelligent platform verifies injection history, confirms meningioma diagnosis from MRI/CT reports, builds exposure timelines, and routes viable claims to attorneys — all without replacing your existing CRM or case management system.

Depo-Provera MDL 3140 Intake Automation

MDL 3140 in the Northern District of Florida centralizes Depo-Provera meningioma cases. Case Compass automates the evidence collection required for MDL threshold proof requirements: confirmed DMPA exposure, confirmed meningioma diagnosis, and treatment documentation.

Keywords

Depo-Provera meningioma lawsuit intake, DMPA MDL 3140 software, depo shot brain tumor case evaluation, injectable medroxyprogesterone acetate litigation intake, pharmaceutical mass tort intake automation, meningioma medical record verification, depo-provera claim scoring, mass tort intake software, plaintiff law firm CRM integration, depo-provera case management software.